Manila, Philippines – July 8, 2025 — Landing Med, a global leader in AI-powered cervical cancer screening, has been recognized with a Top 3 Innovation Award at the inaugural Asian Development Bank (ADB) INSPIRE Health Forum, held from July 7–11, 2025. The award highlights Landing Med’s commitment to scalable, affordable healthcare AI-powered cytology innovation and its growing role in advancing women’s health equity worldwide.
Invited to present during the Innovation Pitch session, Lan Wang, Head of Global Marketing at Landing Med, introduced the company’s transformative AI-driven cervical cancer screening program. To date, the solution has enabled over 12 million cervical cytology screenings, demonstrating significant impact across underserved communities.
Landing Med’s AI platform reflects a critical evolution in digital health—moving from isolated tool development toward outcome-oriented, service-based healthcare delivery. Proven effective across China’s grassroots healthcare system, the solution is now drawing global attention for democratizing cervical cytology screening, mainly for its cost-effectiveness, accessibility, and scalability.
During the forum’s session on AI innovations in the People’s Republic of China, Dr. Ma Jing, Professor at Tsinghua University’s Institute of Hospital Management, presented findings from a five-year follow-up study on Landing Med’s AI screening program. The study showed the system not only significantly reduced cervical cancer mortality but also lowered overall healthcare costs by reducing outpatient visits, hospitalizations, and related expenditures—highlighting its dual value in improving health outcomes and resource efficiency.
Landing Med’s participation in the ADB forum reinforces its expanding influence in global public health. By integrating cutting-edge digital technology with a deep commitment to accessibility, the company is advancing its mission to transform women’s health and reduce disparities through innovative, AI-powered diagnostics.
CN
